Posted by Michael Wonder on 26 Mar 2019
Cancer Society critical of PHARMAC saying they 'lack accountability, lack transparency, are slow'
26 March 2019 - PHARMAC "lack accountability, lack transparency, are slow", in delivering pharmaceutical drugs to New Zealanders who need them according to the Cancer Society.
This morning on TVNZ1's Breakfast, Cancer Society's medical director Dr Chris Jackson said it was "beyond any shadow of a doubt" the access to cancer drugs and treatment was better in Australia, Canada and the UK than in New Zealand.
"The UK internationally is regarded as a low-tide mark for access to drugs and we're even behind them," Dr Jackson said.
